Lysteda approved for heavy menstrual bleeding
The FDA has approved Lysteda (tranexamic acid tablets, from Xanodyne), a non-hormonal treatment for women suffering from menorrhaghia, cyclic heavy menstrual bleeding (HMB).
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.